YS Biopharma Co. Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	Current	2022	2021	2020
Market Capitalization	166	149	250	-
Market Cap Growth	-	-40.45%	-	-
Enterprise Value	197	277	360	-372
PE Ratio	-	-0.35	-0.68	-
PS Ratio	-	0.22	0.50	-
PB Ratio	2.29	0.20	-0.36	-
P/FCF Ratio	-	-0.63	-0.53	-
P/OCF Ratio	-	-0.82	-1.44	-
EV/Sales Ratio	-	0.40	0.71	-1.45
EV/EBITDA Ratio	-	-1.32	-1.85	2.84
EV/EBIT Ratio	-	-1.10	-1.57	2.31
EV/FCF Ratio	-	-1.18	-0.77	1.06
Debt / Equity Ratio	1.18	0.68	-0.54	-0.04
Debt / EBITDA Ratio	-	-2.37	-1.96	-0.14
Debt / FCF Ratio	-	-2.12	-0.81	-0.05
Quick Ratio	0.71	1.27	1.22	1.87
Current Ratio	0.94	1.57	1.61	2.13
Asset Turnover	-	0.44	0.98	-
Interest Coverage	-	-8.15	-84.28	-5.43
Return on Equity (ROE)	-	-2859.00%	199.70%	-
Return on Assets (ROA)	-	-26.70%	-71.80%	-
Return on Capital (ROIC)	-	-11.36%	37.36%	25.66%
Earnings Yield	-283.06%	-146.91%	-
FCF Yield	-157.94%	-187.52%	-
Buyback Yield / Dilution	-50.62%	-50.51%	-	-
Total Shareholder Return	-50.62%	-50.51%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).